Moolec Science SA 20-F annual reports
The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.
NASDAQ
Moolec Science SA reported substantial doubt about its ability to continue as a going concern, with significant operating losses and negative working capital for the fiscal year ended June 30, 2025.
NASDAQ
Moolec Science SA reports its financial results and operational activities for the fiscal year ending June 30, 2024, highlighting its progress in molecular farming and key strategic initiatives.